Stay updated on Dapagliflozin at Discharge Reduces Heart Failure Readmission Clinical Trial

Sign up to get notified when there's something new on the Dapagliflozin at Discharge Reduces Heart Failure Readmission Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Dapagliflozin at Discharge Reduces Heart Failure Readmission Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    Record History shows a new revision entry (v3.3.2) added and an older revision (v3.2.0) removed. This is a backend version-tracking update and does not modify study data or visible content.
    Difference
    0.1%
    Check dated 2025-11-25T10:53:15.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The notice about government funding operating status has been removed from the page, while the core trial record content remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.7%
    Check dated 2025-11-18T06:58:04.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Only minor UI/layout changes and a new entry appear in the Record History. There are no changes to core study data such as enrollment, status, or outcomes; to avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-03T21:06:57.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    Major changes: updated operating status notice and version to v3.2.0; removal of v3.1.0.
    Difference
    12%
    Check dated 2025-10-06T05:31:45.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    - Updated version from v3.0.2 to v3.1.0. - No other content changes detected.
    Difference
    0.3%
    Check dated 2025-09-29T03:05:37.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    Revision updated to v3.0.2 and Back to Top removed; no core content or critical information is affected.
    Difference
    0.7%
    Check dated 2025-09-14T19:25:07.000Z thumbnail image

Stay in the know with updates to Dapagliflozin at Discharge Reduces Heart Failure Readmission Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Dapagliflozin at Discharge Reduces Heart Failure Readmission Clinical Trial page.